- Anniversary/History
- Membership
- Publications
- Resources
- Education
- Events
- Outreach
- Careers
- About
- For Pain Patients and Professionals
2020 Feb
Biol Blood Marrow Transplant
26
2
An open label phase 2 study of topical dexamethasone versus tacrolimus solutions in new onset oral chronic graft-versus-host disease (cGVHD) revealed superior efficacy of dexamethasone. The objective of this study was to report long-term patterns of topical therapy utilization and clinical outcomes in this cohort after completing the 30-day trial.